Clinical Trial Update: Effect of Nilotinib in Cerebellar Ataxia Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update on nilotinib for cerebellar ataxia shows completion of study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ataxia Progressive
• Cerebellar Ataxia

Drugs mentioned

• Nilotinib (nilotinib)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Ataxia, Cerebellar, Ataxia, Progressive | Phase 2 | Status: COMPLETED